A case of chylothorax in newborn is described. A the fifteenth day a sudden respiratory distress for chylothorax has appeared. A continuous drainage, after thoracenteses, has been placed; the clinic course has been favourable and, at five day, we have started with MCT feeding.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Nutritional, Metabolic, and Inflammatory Alterations in Children with Chylous Effusion in the Postoperative Period of Cardiac Surgery: A Descriptive Cohort.
Nutrients
November 2024
Medical Clinical Department, State University of Campinas (UNICAMP), Campinas 13083-970, Brazil.
Article Synopsis
- The study focuses on the rising occurrence of chylous effusion in children post-cardiac surgery, highlighting the need to understand the clinical profiles of affected patients.
- A retrospective analysis of 23 patients, mostly young (average age of 6 months) and often malnourished, revealed significant complications like lymphopenia and hypoalbuminemia at the time of diagnosis.
- The findings emphasize the importance of close clinical and laboratory monitoring post-surgery to detect early signs of chylous effusion and initiate prompt treatment to prevent adverse outcomes.
Refractory Chylothorax and Ventricular Hypertrophy Treated with Trametinib in a Patient with Noonan Syndrome: 18-Month Follow-Up.
Children (Basel)
October 2024
Medical Genetics Unit, Santobono-Pausilipon Children's Hospital, 80129 Naples, Italy.
RASopathies are a group of genetic syndromes caused by germline mutations in genes involved in the RAS/Mitogen-Activated Protein Kinase signaling pathway, which regulates cellular proliferation, differentiation, and angiogenesis. Despite their involvement at different levels of this pathway, RASopathies share overlapping clinical phenotypes. Noonan syndrome is the most prevalent RASopathy, with an estimated incidence of 1 in 2500 live births, and it is typically inherited in an autosomal dominant manner, with 50% of cases involving gain-of-function mutations in the PTPN11 gene.
View Article and Find Full Text PDFExperience of patent ductus arteriosus ligation during extracorporeal membrane oxygenation treatment in newborns with severe respiratory failure due to persistent pulmonary hypertension: a single-center retrospective study.
Ital J Pediatr
November 2024
Department of Cardiac Surgery, Fujian Children's Hospital (Fujian Branch of Shanghai Children's Medical Center), College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China.
Background: The aim of this study is to summarize our center's experience with patent ductus arteriosus (PDA) ligation during extracorporeal membrane oxygenation (ECMO) treatment in newborns with severe respiratory failure due to persistent pulmonary hypertension of the newborn (PPHN).
Methods: We retrospectively collected and analyzed clinical data from five newborns with severe respiratory failure due to PPHN who underwent PDA ligation during ECMO treatment at our hospital between January 2021 and August 2023.
Results: All five patients had large PDAs, measuring 10 mm, 6 mm, 6 mm, 7 mm, and 6 mm, respectively.
Cytokines in chest tube drainage after pediatric cardiac surgery - Is chylothorax the only phenotype?
Cytokine
December 2024
University of Utah, Department of Pediatrics, Division of Pediatric Critical Care, 30 N. Mario Capecchi Dr, Salt Lake City, UT 84112, United States.
Background: Chylothorax after pediatric cardiac surgery is associated with increased morbidity and mortality. Poor understanding exists regarding inflammation within the pleural fluid. Our aim was to determine the relationship between proinflammatory markers and chylothorax.
View Article and Find Full Text PDFRisk factors and early outcomes associated with prolonged pleural effusion/chylothorax after paediatric cardiac surgery.
Eur J Cardiothorac Surg
October 2024
Cardiology and Intensive Care Departments, Bristol Royal Hospital for Children and the Heart Institute, Bristol, UK.
Article Synopsis
- Prolonged pleural effusion/chylothorax (PPE/C) is a complication in pediatric cardiac surgery that has not been thoroughly studied, prompting this investigation into its incidence, risk factors, and impact on outcomes.
- A multicentre study collected data on multiple post-operative complications across 5 UK hospitals, finding that PPE/C occurred in 6.5% of patients, typically 6 days after surgery, and increased mortality primarily in patients with multiple other complications.
- The study concludes that while PPE/C is associated with increased mortality, it does not significantly extend hospital length of stay in cases with multiple complications, highlighting the need for effective prevention and management strategies for PPE/C in complex post-operative care.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!